Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne

Stock Information for MDxHealth SA

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About MDxHealth SA

Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025
Mdxhealth to Release Third Quarter 2025 Financial Results on November 12
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change
MDxHealth Reports Q1-2025 Results
Mdxhealth to Release First Quarter 2025 Financial Results on May 14
Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results
Mdxhealth to Present Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on February 26

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.